Eliem Therapeutics Inc [NASDAQ: ELYM] traded at a low on Wednesday, posting a -16.16 loss after which it closed the day’ session at $5.50.
The results of the trading session contributed to over 5336414 shares changing hands. Over the past one week, the price volatility of Eliem Therapeutics Inc stands at 20.02% while the volatility over the past one month is 11.02%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for ELYM stock reached $368.83 million, with 67.06 million shares outstanding and 51.90 million shares in the current float. Compared to the average trading volume of 378.34K shares, ELYM reached a trading volume of 5336414 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Eliem Therapeutics Inc [ELYM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELYM shares is $4.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELYM stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Eliem Therapeutics Inc is set at 0.80 The Price to Book ratio for the last quarter was 1.65, with the Price to Cash per share for the same quarter was set at 3.33. Price to Free Cash Flow for ELYM in the course of the last twelve months was 6147.17 with Quick ratio for the last quarter at 60.41.
How has ELYM stock performed recently?
Eliem Therapeutics Inc [ELYM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.08. With this latest performance, ELYM shares dropped by -7.56% in over the last four-week period, additionally plugging by 102.95% over the last 6 months – not to mention a rise of 102.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELYM stock in for the last two-week period is set at 32.33, with the RSI for the last a single of trading hit 24.56, and the three-weeks RSI is set at 37.23 for Eliem Therapeutics Inc [ELYM]. The present Moving Average for the last 50 days of trading for this stock 7.23, while it was recorded at 7.28 for the last single week of trading, and 5.32 for the last 200 days.
Eliem Therapeutics Inc [ELYM]: Deeper insight into the fundamentals
Eliem Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 60.41 and a Current Ratio set at 60.41.
Earnings analysis for Eliem Therapeutics Inc [ELYM]
With the latest financial reports released by the company, Eliem Therapeutics Inc posted -0.56/share EPS, while the average EPS was predicted by analysts to be reported at -0.47/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.09. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELYM.
Insider trade positions for Eliem Therapeutics Inc [ELYM]
There are presently around $77.67%, or 86.67%% of ELYM stock, in the hands of institutional investors. The top three institutional holders of ELYM stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 31.42 million shares, which is approximately 103.5246%. DEEP TRACK CAPITAL, LP, holding 3.9 million shares of the stock with an approximate value of $$27.76 million in ELYM stocks shares; and DEEP TRACK CAPITAL, LP, currently with $$23.19 million in ELYM stock with ownership which is approximately 10.7461%.
